Slide 1: FY25 AGM Presentation
RAP©️ FY25 AGM Presentation ASX: UCM • Resolutions & Voting • Overview, products and markets • Milestones • FY2025 Results • FY2026 Drivers Prof. Rob Phillips Founder and Chairman, Uscom Limited Nov 27, 2025
Slide 2: USCOM Vision
Overview USCOM Vision World leading medical technology (ASX:UCM) with global footprint – Sydney, Singapore, Beijing, Budapest, London Delaware • Cardiovascular and pulmonary devices • Expanding product portfolio • Digital technology • Wireless connectivity • Flagship science and technology in presti
Slide 3: Non-invasive Medical Devices Improving Clinical Care And Patient Outcomes
Product Non-invasive Medical Devices Improving Clinical Care And Patient Outcomes USCOM 1A Non-invasive Hemodynamic Monitor Central BP and Pulse Wave Analysis Monitor Ultrasonic Spirometer Flagship digital Doppler device enabling Patented technology measuring central aortic Digital ultrasonic spirom
Slide 4: USCOM's Journey
Milestones USCOM’s Journey 1999 2015 2022 2025 • Uscom Limited established • Acquired Thor Laboratories to • Entered strategic partnership with • Uscom became corporate transform to SpiroSonic Foxconn member of AustCham China. 2003 • Received Break-through • ASX listed – UCM 2017 2023 Technology Awa
Slide 5: Global Footprint
Milestones Global Footprint Belgium – Mons Université de Mons Slovenjia – Lubiana Poland – Lodz Chongqing University Medical Centre Polish Mother’s Chongqing Beijing PERIN Chicago Memorial Hospital Children's Hospital Fuwai Cardiovascular Hospital Italy – Roma Uscom Training and Illinois Children’s
Slide 6: Operational Milestones
Milestones Operational Milestones Sinopharm Partnership • SinoPharm is one of China’s largest medical device distributors and has signed a cooperative agreement with Uscom China for development of new marketing and sale initiatives. This collaboration will allow SinoPharm to diversify from principal
Slide 7: FY25 Results - Globally
FY25 Results FY25 Results - Globally UCM Total Receipts Trend FY12 – FY26* 19% $2.58 million $3.16 million 25% Sale of Products Total Revenue Down in Revenue 29% CAGR* (14yrs) CAGR (8yrs Pre-covid) Building the future Results • Sale of products $2.58m • Revenue from ordinary activities down 25%, Sal
Slide 8: FY25 Results - Regionally
FY25 Results FY25 Results - Regionally Uscom Total Revenue by Region 19% Asia 8% 47% Europe US/Other Australia 26% • Global platform for growth • Hedged for currency and shifting geopolitics • Global reporting, tax, transfer pricing and auditing 11
Slide 9: FY26 Drivers
FY26 Drivers FY26 Drivers • China: o Uscom’s partnership with Foxconn is expanding into a new high technology Medtech centre in Daxing, an outer suburb of Beijing. Eventually, this centre will provide supply chain and manufacturing capabilities for all Uscom devices worldwide. o The Uscom–SinoPharm
Slide 10: Conclusion
Conclusion Conclusion FY25 was a year of adaptation for Uscom Limited. Navigated unpredictable global geopolitics. Trade wars, tariff wars, currency wars, and military conflicts across multiple continents and markets. Global team has maintained sales focus in preparation for the inevitable recovery
Slide 11: Australian Wildlife Conservancy (AWC)
Corporate Social Responsibility Australian Wildlife Conservancy (AWC) Australia is the extinction capital of the world In 15 years the list of threatened species has increased by 36% 87% of Australia’s mammals, 93% of our reptiles, 94% of our frogs, and 45% of our bird species are unique to Australi
Slide 12: FY25 AGM Presentation
RAP©️ FY25 AGM Presentation ASX: UCM • Resolutions & Voting • Overview, products and markets • Milestones • FY2025 Results • FY2026 Drivers Prof. Rob Phillips Founder and Chairman, Uscom Limited Nov 27, 2025